CPIX — Cumberland Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Cumberland Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	27	19.8	18.3	18	11.4
Net Total Accounts Receivable
Net Total Receivables	6.88	13.2	9.76	11.7	16.9
Total Inventory
Prepaid Expenses
Total Current Assets	45.7	45.9	35.7	36.5	37.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.47	5.5	7.04	6.45	8.61
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	84.5	92.9	81.8	75.6	76.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19.3	28.6	28	31.6	36.7
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	41.6	56.7	52.2	52.7	51.9
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	42.8	36.3	29.6	22.9	24.9
Total Liabilities & Shareholders' Equity	84.5	92.9	81.8	75.6	76.8
Total Common Shares Outstanding